Case number IPR2019-00345
Maia Pharmaceuticals, Inc. v. Bracco Diagnostics Inc. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Aug 7, 2019 | 12 | Notice of Refund Download | |
| Jul 23, 2019 | 11 | Petitioner's Request for Refund of Post-Institution Fees Download | |
| May 31, 2019 | 10 | Trial Instituted Document Download | |
| Mar 4, 2019 | 2006 | Bracco's Expert Declaration Concerning Markman Brief Download | |
| Mar 4, 2019 | 2004 | Bracco's Responses to Invalidity Contentions Download | |
| Mar 4, 2019 | 2008 | Maia's Expert Declaration Concerning Markman Brief Download | |
| Mar 4, 2019 | 2013 | Response to Office Action filed Feb. 19, 2019, in US2019/0060240 Download | |
| Mar 4, 2019 | 2009 | US Patent No. 5,574,136 Download | |
| Mar 4, 2019 | 2002 | Citizen Petition Download | |
| Mar 4, 2019 | 2012 | Original (as filed) claims of US2019/0060240 Download | |
| Mar 4, 2019 | 2011 | U.S. Provisional Patent Application No. 62/550,484 Download | |
| Mar 4, 2019 | 2007 | Maia Opening Markman Brief Download | |
| Mar 4, 2019 | 9 | Patent Owner's Preliminary Response Download | |
| Mar 4, 2019 | 2001 | Amended Joint Claim Construction and Prehearing Statement Download | |
| Mar 4, 2019 | 2005 | Bracco's Opening Markman Brief Download | |
| Mar 4, 2019 | 2003 | Maia Invalidity Contentions Download | |
| Mar 4, 2019 | 2010 | US Patent Application Publication No. 2019/0060240 Download | |
| Feb 19, 2019 | 7 | Patent Owner's Submission of Updated Mandatory Notice Information Download | |
| Feb 19, 2019 | 8 | Patent Owner's Updated Power Of Attorney Download | |
| Dec 10, 2018 | 4 | Patent Owner's Submission of Mandatory Notice Information Download | |
| Dec 10, 2018 | 6 | Patent Owner's Power of Attorney Download | |
| Dec 10, 2018 | 5 | Patent Owner's Submission of Mandatory Notice Information Download | |
| Dec 4, 2018 | 3 | Notice of Accord Filing Date Download | |
| Nov 19, 2018 | 1015 | U.S. Patent No. 3,937,819 to Ondetti et al. Download | |
| Nov 19, 2018 | 1012 | Liddle, R. A., On the Measurement of Cholecystokinin, 44 Clinical Chemistry 5 (1998) Download | |
| Nov 19, 2018 | 1025 | Marseigne, et al., Full Agonists of CCK8 Containing a Nonhydrolyzable Sulfated Tyrosine Residue, 32 J. Med. Chem. 445 (1989) Download | |
| Nov 19, 2018 | 1042 | Liddle, et al., Cholecystokinin Bioactivity in Human Plasma, 75 J. Clin. Invest. 1144 (1985) Download | |
| Nov 19, 2018 | 1040 | Wang et al., Lyophilization and Development of Solid Protein Particles, 203 Int. J. of Pharm. 1 (2000) Download | |
| Nov 19, 2018 | 1016 | Wang et al., Review of Excipients and pHs for Parenteral Products Used in the United States, 34 PDA J. Pharm. Sci and Tech. 452 (1980) Download | |
| Nov 19, 2018 | 1009 | Bacarese-Hamilton et al., Oxidation/Reduction of Methionine Residues in CCK: A Study by Radioimmunoassay and Isocratic Reverse Phase High Pressure Liquid Chromatography, 6 Peptides 17 (1985) Download | |
| Nov 19, 2018 | 1045 | Graf, et. al., ¿¿¿Iron-catalyzed Hydroxyl Radical Formation,¿¿¿ 259 J. Bio. Chem. 3620 (1984) Download | |
| Nov 19, 2018 | 1013 | Akers et al., Peptides and Proteins as Parenteral Solutions, in Pharmaceutical Formulation Development of Peptides and Proteins (2000) Download | |
| Nov 19, 2018 | 1033 | FDA Approval Package for NDA Application Number 017697-S012. Download | |
| Nov 19, 2018 | 1014 | DeLuca, et al., Formulation of Small Volume Parenterals, in Pharmaceutical Dosage Forms: Parenteral Medications Volume 1 (1992) Download | |
| Nov 19, 2018 | 1030 | Essentials of Nuclear Medicine Science (Hladik, et al., eds., 1987) Download | |
| Nov 19, 2018 | 1002 | Prosecution History excerpts for the 046 patent Download | |
| Nov 19, 2018 | 1017 | Nema et al., Excipients and Their Use in Injectable Products, 51 PDA J. of Pharma. Sci. and Tech. 166 (1997) Download | |
| Nov 19, 2018 | 1023 | Moroder et al., Gastrin and Cholecystokinin, An Arduous Task for the Peptide Chemist in Natural Product Chemistry (1986) Download | |
| Nov 19, 2018 | 1044 | Banga, A.K., Structure and Analysis of Therapeutic Peptides and Proteins (2006) Download | |
| Nov 19, 2018 | 1032 | U.S. Patent No. 5,272,135 to Takruri Download | |
| Nov 19, 2018 | 1007 | PCT Publication No. WO 00/5169 to Sato (English Translation with affidavit) Download | |
| Nov 19, 2018 | 1019 | Wang et al., Parenteral Formulations of Proteins and Peptides: Stabilities and stabilizers, 42 J. Parenteral Sci. and Tech. S4 (1988) Download | |
| Nov 19, 2018 | 1046 | U.S. Patent No. 6,238,664 to Hellerbrand et al. Download | |
| Nov 19, 2018 | 1001 | U.S. Patent No. 6,803,046 to Metcalfe et al. Download | |
| Nov 19, 2018 | 1018 | U.S. Patent Publication No. 2003/0104996 to Li et al. Download | |
| Nov 19, 2018 | 1010 | U.S. Patent No. 7,329,644 to Saviano et al. Download | |
| Nov 19, 2018 | 1041 | Bush et al., A critical evaluation of clinical trials in reactions to sulfites, 78 J. Allergy Clin. Immunol. 191 (1986) Download | |
| Nov 19, 2018 | 1035 | Handbook of Pharmaceutical Excipients, Third Edition, Arthur H. Kibbe, Ed. (2000) Download | |
| Nov 19, 2018 | 2 | Petition Download | |
| Nov 19, 2018 | 1043 | Konturek, et al., Effect of Cholecystokinin Receptor Antagonist on Pancreatic Responses (1988) Download | |
| Nov 19, 2018 | 1006 | PCT Publication No. WO 00/5169 to Sato Download | |
| Nov 19, 2018 | 1029 | Package Insert for KINEVAC Sincalide for Injection, November 1994 Download | |
| Nov 19, 2018 | 1024 | Yoshioka, et al., Stability of Peptide and Protein Pharmaceuticals in Stability of Drugs and Dosage Forms (2002) Download | |
| Nov 19, 2018 | 1 | Petitioner Power of Attorney Download | |
| Nov 19, 2018 | 1028 | Wang, Y.J., Parenteral Products of Peptides and Proteins, in Pharmaceutical Dosage Forms: Parenteral Medications Volume 1 (1992) Download | |
| Nov 19, 2018 | 1022 | Huttner, W. B., Determination and Occurrence of Tyrosine O-Sulfate in Proteins, 107 Methods in Enzymology 200 (1984) Download | |
| Nov 19, 2018 | 1003 | Declaration of Christian Schoneich, Ph.D. Download | |
| Nov 19, 2018 | 1031 | Uffelman, W., Unexpected Shortfalls of Two Nuclear Medicine Pharmaceuticals, 42 J. Nuc. Med. 16N (2001) Download | |
| Nov 19, 2018 | 1036 | Jensen et al., Metal-Catalyzed Oxidation of Brain-Derived Neurotrophic Factor (BDNF) Download | |
| Nov 19, 2018 | 1008 | Bacarese-Hamilton et al., Prevention of Cholecystokinin Oxidation During Tissue Extraction, 448 Neuronal Cholecystokinin 571 (1985) Download | |
| Nov 19, 2018 | 1005 | Physicians Desk Reference For Radiology and Nuclear Medicine, 1977/78 (1977) (PDR) Download | |
| Nov 19, 2018 | 1004 | CV of Christian Schoneich, Ph.D. Download | |
| Nov 19, 2018 | 1034 | Fendler et al., Hydrolysis of Nitrophenyl and Dinitrophenyl Sulfate Esters, 33 J. Org. Chem. 10 3852 (1968) Download | |
| Nov 19, 2018 | 1020 | Wunsch, E., Peptide Factors as Pharmaceuticals: Criteria for Application, 22 Biopolymers 493 (1983) Download | |
| Nov 19, 2018 | 1021 | Yagami, et al., Stabilization of a tyrosine O-sulfate residue by a cationic functional group: , 56 J. Peptide Res. 239 (2000) Download | |
| Nov 19, 2018 | 1011 | Rational Design of Stable Protein Formulations: Theory and Practice, Chapters 5 & 8 (Carpenter and Manning, ed., April 30, 2002) Download | |
| Nov 19, 2018 | 1026 | Gorman et al., Proton Affinities of the 20 Common -Amino Acids, 114 J. Am. Chem. Soc. 3986 (1992) Download | |
| Nov 19, 2018 | 1027 | Liddle, R. A., Cholecystokinin Cells, 59 Annu. Rev. Physiol. 221 (1997) Download | |
| Nov 19, 2018 | 1039 | Mattern et al., Formulation of Proteins in Vacuum-Dried Glasses. II. Process and Storage Stability in Sugar-Free Amino Acid Systems, Download | |
| Nov 19, 2018 | 1037 | Jensen et al., Metal-Catalyzed Oxidation of Brain-Derived Neurotrophic Factor (BDNF): Selectivity and Conformational Consequences of Histidine Modification, (2000) Download | |
| Nov 19, 2018 | 1038 | Swadesh, et al., Sodium Sulfite as an Antioxidant in the Acid Hydrolysis of Bovine Pancreatic Ribonuclease A, 141 Analytical Biochemistry 397 (1984) Download |
